HSCT | Multiple Sclerosis Society UK
Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range? - Kabat - 2020 - STEM CELLS Translational Medicine - Wiley Online Library
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines: Trends in Molecular Medicine
Frontiers | Stem Cell Therapies for Progressive Multiple Sclerosis | Cell and Developmental Biology
First results of new stem cell therapy trial announced | Multiple Sclerosis Society UK
Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis | npj Regenerative Medicine
Drugs in Development for Multiple Sclerosis - Practical Neurology
NG-01 Stem Cell Therapy for MS Shows Neuroprotective Effects in Trial
Stem Cell Therapies for AutoImmune Diseases such as Multiple Sclerosis
Prospective clinical trials for HSCT in MS. Choice of trial design.... | Download Scientific Diagram
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases - The Lancet Neurology
Clinical trials using mesenchymal stem cells in MS patients | Download Scientific Diagram
Stem Cell Therapy, A New Multiple Sclerosis Breakthrough in 2022?
Clinical trials for stem cell therapies | BMC Medicine | Full Text
Stem cells and MS - AHSCT | MS Trust
Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis | npj Regenerative Medicine
Clinical trials and research bring hope to MS patients
Last 5 Years Clinical Trials Using TSCs on MS Patients (23) | Download Table
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint ...
New Clinical Trial Compares Stem Cell Transplantation to Currently Available Drugs for MS | Technology Networks
Multiple Sclerosis and Stem Cell Treatments
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial - The Lancet
MS Treatment with Umbilical Cord Stem Cells Safe, Effective, Trial Finds
